Pharmacological characterization of EK112, a new combined angiotensin II and thromboxane A 2 receptor antagonist

Author： Hwang T.-L.   Yeh Y.-A.   Chern J.-W.   Teng C.-M.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.34, Iss.1, 2000-01, pp. : 25-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist

By Cazes M.   Provost D.   Versigny A.   Cloarec A.  

European Journal of Pharmacology, Vol. 284, Iss. 1, 1995-09 ,pp. : 157-170

Elsevier

Access to resources Recommend Favorite

In vitro pharmacological characterization of a new selective angiotensin AT 1 receptor antagonist, UR-7280

By De Arriba A.F.   Gomez-Casajus L.A.   Cavalcanti F.   Almansa C.   Garcia-Rafanell J.   Forn J.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 341-347

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist

By Nagura J.   Yasuda S.   Fujishima K.   Yamamoto M.   Hui C.   Kawano K.-i.   Katano K.   Ogino H.   Hachisu M.   Konno F.  

European Journal of Pharmacology, Vol. 274, Iss. 1, 1995-02 ,pp. : 201-211

Elsevier

Access to resources Recommend Favorite

ACE Inhibitor, Angiotensin II Receptor Antagonist, Monotherapy or Combined Therapy?

By  

Heart Drug, Vol. 4, Iss. 3, 2004-08 ,pp. : 145-150

Karger

Access to resources Recommend Favorite

Effect of combined leukotriene D 4 and thromboxane A 2 receptor antagonist on mediator-controlled resistance in guinea pigs

By Arakida Y.   Ohga K.   Okada Y.   Morio H.   Suwa K.   Yokota M.   Yamada T.  

European Journal of Pharmacology, Vol. 403, Iss. 1, 2000-09 ,pp. : 169-179

Elsevier

Access to resources Recommend Favorite